ArticleEuropean journal of nuclear medicine and molecular imaging2022
Higher accuracy of [
Article in European journal of nuclear medicine and molecular imaging, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
37 citing papers in PubMed, 3 syntheses or guidelines pooled it, 55 citations in OpenAlex.
- Revealing the hidden: A systematic review and meta-analysis of FAPI-based tracers imaging for brain metastatic lesions.European journal of nuclear medicine and molecular imaging · 2026Pooled it
- Performance of [European radiology · 2024Pooled it
- Comparison ofFrontiers in oncology · 2023Pooled it
- [European journal of nuclear medicine and molecular imaging · 2025Trial
- Diagnostic value of [Abdominal radiology (New York) · 2026Article
- [European journal of nuclear medicine and molecular imaging · 2026Article
- Preliminary clinical investigation ofEuropean journal of nuclear medicine and molecular imaging · 2026Article
- [European journal of nuclear medicine and molecular imaging · 2026Article
- Diagnostic performance of [European journal of nuclear medicine and molecular imaging · 2026Article
- Fibroblast Activation Protein Inhibitor (FAPI) PET: A Scoping Review of Emerging Oncologic and Fibroinflammatory Applications.Diagnostics (Basel, Switzerland) · 2026Review
- Comparison of [Quantitative imaging in medicine and surgery · 2025Article
- Review
- Insights into lung cancer diagnosis and clinical management using [Annals of nuclear medicine · 2025Article
- [European journal of nuclear medicine and molecular imaging · 2025Article
- Comparison of the diagnostic accuracy betweenJournal of thoracic disease · 2025Article
- Comparison of [Frontiers in oncology · 2025Article
- Comparison ofAbdominal radiology (New York) · 2024Article
- [68Ga]Ga-FAPI-46 PET/CT for Staging Suspected/Confirmed Lung Cancer: Results on the Surgical Cohort Within a Monocentric Prospective Trial.Pharmaceuticals (Basel, Switzerland) · 2024Article
- Preoperative evaluation of mediastinal lymph nodes in non-small cell lung cancer using [European journal of nuclear medicine and molecular imaging · 2024Article
- Imaging at the nexus: how state of the art imaging techniques can enhance our understanding of cancer and fibrosis.Journal of translational medicine · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 1 institution in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis study aimed to explore the clinical staging performance of [
methodsA total of 134 diagnosed or suspected NSCLC patients were enrolled in the prospective study (ChiCTR2000038080); they received paired 2-[
resultsFor T diagnosis, [
conclusionCompared with 2-[
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.